Jove
Visualize
Contact Us

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

782
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
782
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

49.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.0K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

4.4K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.4K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.8K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K
Standard Precaution01:26

Standard Precaution

2.7K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.7K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

763
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
763

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The context, science and practice of gender-affirming care.

Nature medicine·2022
Same author

Correlates of Engagement in HIV Care Among Transgender Women of Color in the United States of America.

AIDS and behavior·2021
Same author

Implementation Strategies for Creating Inclusive, All-Women HIV Care Environments: Perspectives From Trans and Cis Women.

Women's health issues : official publication of the Jacobs Institute of Women's Health·2021
Same author

Inclusion as illusion: erasing transgender women in research with MSM.

Journal of the International AIDS Society·2021
Same author

Brief Report: HIV Testing, Diagnosis of HIV Infection, Linkage to Medical Care, and Interview for Partner Services Among Transgender Persons-United States, 2012-2017.

Journal of acquired immune deficiency syndromes (1999)·2021
Same author

<i>We Are All Women</i>: Barriers and Facilitators to Inclusion of Transgender Women in HIV Treatment and Support Services Designed for Cisgender Women.

AIDS patient care and STDs·2020
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 29, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.8K

Comprehensive HIV Prevention for Transgender Persons.

Mary Spink Neumann1, Teresa J Finlayson1, Nicole L Pitts1

  • 1Mary Spink Neumann and Teresa J. Finlayson are with the Office of the Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Nicole L. Pitts is with ICF International, Atlanta. JoAnne Keatley is with the Department of Family and Community Medicine, University of California, San Francisco.

American Journal of Public Health
|December 21, 2016
PubMed
Summary

Transgender individuals face high HIV risks due to complex factors. Integrating HIV prevention with medical, legal, and psychosocial support is crucial for improving health outcomes and reducing transmission risk.

More Related Videos

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

9.0K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.0K

Related Experiment Videos

Last Updated: Dec 29, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.8K
Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

9.0K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.0K

Area of Science:

  • Public Health
  • Epidemiology
  • Social Sciences

Background:

  • Transgender populations experience disproportionately high rates of HIV infection.
  • Existing HIV prevention efforts for transgender people are limited and often insufficient.
  • Multiple individual, interpersonal, social, and structural factors contribute to elevated HIV risk in this group.

Purpose of the Study:

  • To highlight the need for comprehensive HIV prevention strategies tailored to transgender individuals.
  • To explore the benefits of integrating HIV prevention with broader health and social services.
  • To identify current and future directions for HIV prevention interventions targeting transgender populations.

Main Methods:

  • Review of current HIV prevention initiatives for transgender persons.
  • Analysis of individual, interpersonal, social, and structural determinants of HIV risk.
  • Conceptual framework for multi-level intervention strategies.

Main Results:

  • Current HIV prevention efforts for transgender people are minimal.
  • A combination of HIV prevention and complementary services can simultaneously address risk behaviors and determinants.
  • Multi-level interventions encompassing socioeconomic factors, clinical care, and education are necessary.

Conclusions:

  • Comprehensive HIV prevention for transgender persons requires integrated, multi-level approaches.
  • Combining HIV prevention with medical, legal, and psychosocial services can significantly impact health.
  • Future efforts should focus on expanding and refining targeted interventions for this vulnerable population.